RAPID ACCESS TO INTERVENTION DEVELOPMENT (RAID)

RELEASE DATE:  December 12, 2003

NOTICE:  NOT-CA-04-003

National Cancer Institute (NCI)
 (http://www.nci.nih.gov)

The NATIONAL CANCER INSTITUTE (NCI) is requesting applications for the following 
initiative: Rapid Access to Intervention Development (RAID).  RAID will make 
available to academic investigators, on a competitive basis, the preclinical 
development contract resources of NCI’s Developmental Therapeutics Program (DTP).  
RAID is not a grant program.  Approved applications to RAID instead gain access to 
the drug development contract resources of the Developmental Therapeutics Program.  
The goal of RAID is the rapid movement of novel molecules and concepts from the 
laboratory to the clinic for proof-of-principle clinical trials.  RAID will assist 
investigators who submit successful applications by providing any (or all) of the 
preclinical development steps that may be obstacles to clinical translation.  
Possible tasks may include production, bulk supply, good manufacturing process (GMP) 
manufacturing, formulation, and toxicology.  Suitable agents for RAID will include 
small molecules, biologics, or vaccines.  

There are two receipt dates, February 1 and August 1, for requests for RAID support 
per year.  Current requests must be received by February 1, 2004, with all materials 
submitted directly to the office listed below.   

For information on the procedure for requesting RAID resources, visit the DTP web 
site http://dtp.nci.nih.gov/.  Inquiries are encouraged and DTP staff welcome 
opportunities to clarify issues or answer questions about the RAID program.  
Academic investigators may have collaborations with small-business partners and 
still qualify for RAID funding.  Non-profit organizations other than universities 
may also submit RAID applications.  Please note that a maximum of two distinct 
requests for support per investigator can be submitted for each receipt date. 

INQUIRIES:

Inquiries regarding this notice may be directed to: 

RAID
Office of Associate Director
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Blvd., EPN Suite 8022
Bethesda, MD 20892-7458 (U.S. mail)
Rockville, MD 20852 (for express/courier service)
Telephone: 301-496-8720
Fax: 301-402-0831
Email: raid@dtpax2.ncifcrf.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.